Free Trial

Anterix (ATEX) 10K Form and Latest SEC Filings 2026

Anterix logo
$55.92 +2.71 (+5.09%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$56.01 +0.09 (+0.17%)
As of 05/8/2026 06:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Anterix SEC Filings & Recent Activity

Anterix (NASDAQ:ATEX) has submitted 499+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Anterix's financial statements. The most recent filing was a Form 8-K/A submitted on April 21, 2026.

Form 4
Anterix Inc. Reports Ownership Change on Mar. 4, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Anterix Files Current Report on Apr. 21, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Anterix Files Quarterly Report on Nov. 12, 2025

The 10-Q contains Anterix's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Anterix SEC Filing History

Browse Anterix's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
04/21/2026 8:16 AM
Anterix (1304492) Filer
Form 8-K/A
04/21/2026 6:32 AM
Anterix (1304492) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2026 3:44 PM
Anterix (1304492) Subject
Gerbrandt Ryan (1821509) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/06/2026 6:31 AM
Anterix (1304492) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2026 6:30 AM
Anterix (1304492) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2026 4:49 PM
Anterix (1304492) Issuer
Ashe Gena L (1669943) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 4:39 PM
Anterix (1304492) Subject
Gerbrandt Ryan (1821509) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2026 3:47 PM
Anterix (1304492) Subject
Gerbrandt Ryan (1821509) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2026 6:38 AM
Anterix (1304492) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2026 12:30 PM
Anterix (1304492) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
01/07/2026 6:30 AM
Anterix (1304492) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2025 7:16 AM
Anterix (1304492) Issuer
Lang Scott A. (1571601) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 3:21 PM
Anterix (1304492) Issuer
Lang Scott A. (1571601) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2025 12:42 PM
Anterix (1304492) Issuer
Ashe Gena L (1669943) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2025 4:11 PM
Anterix (1304492) Subject
Ashe Gena L (1669943) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2025 4:20 PM
Anterix (1304492) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2025 4:21 PM
Anterix (1304492) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2025 6:15 PM
Anterix (1304492) Issuer
Marquez Elena (2090789) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2025 6:10 PM
Anterix (1304492) Issuer
Martin Heather (2090798) Reporting
Form 3
Initial statement of beneficial ownership of securities  
11/04/2025 6:11 PM
Anterix (1304492) Issuer
Marquez Elena (2090789) Reporting
Form 3
Initial statement of beneficial ownership of securities  
10/17/2025 5:05 PM
Anterix (1304492) Subject
BlackRock, Inc. (2012383) Filed by
Form SCHEDULE 13G/A
10/09/2025 3:30 PM
Anterix (1304492) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2025 7:57 AM
Anterix (1304492) Issuer
Lang Scott A. (1571601) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2025 6:27 AM
Anterix (1304492) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2025 8:19 AM
Anterix (1304492) Issuer
Gray Timothy (1629762) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2025 5:51 PM
ALTMAN JEFFREY A (1269751) Reporting
Anterix (1304492) Issuer
Owl Creek Asset Management, L.P. (1313756) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2025 4:49 PM
Anterix (1304492) Issuer
Heard William (2035875) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025 5:58 PM
Anterix (1304492) Issuer
Guttman-McCabe Christopher (1828490) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025 6:06 PM
Anterix (1304492) Issuer
Gerbrandt Ryan (1821509) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025 3:30 PM
Anterix (1304492) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2025 3:38 PM
Anterix (1304492) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
06/16/2025 5:28 PM
Anterix (1304492) Issuer
Kuhn Thomas R. (1571521) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025 1:26 PM
Anterix (1304492) Issuer
Gray Timothy (1629762) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025 1:27 PM
Anterix (1304492) Issuer
Lang Scott A. (1571601) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025 1:28 PM
Anterix (1304492) Issuer
Ashe Gena L (1669943) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025 2:19 PM
Anterix (1304492) Issuer
Ashe Gena L (1669943) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025 2:20 PM
Anterix (1304492) Issuer
Gerbrandt Ryan (1821509) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025 2:21 PM
Anterix (1304492) Issuer
Gray Timothy (1629762) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025 2:21 PM
Anterix (1304492) Issuer
Guttman-McCabe Christopher (1828490) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025 4:33 PM
Anterix (1304492) Issuer
Ashe Gena L (1669943) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025 4:35 PM
Anterix (1304492) Issuer
Gerbrandt Ryan (1821509) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025 4:35 PM
Anterix (1304492) Issuer
Gray Timothy (1629762) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025 4:36 PM
Anterix (1304492) Issuer
Guttman-McCabe Christopher (1828490) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Anterix SEC Filings - Frequently Asked Questions

Anterix (ATEX) has submitted 499+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Anterix's fiscal year ends on March 31. The company typically files its 10-K annual report by the end of May, covering the prior fiscal year's financial results. Key financial data from these reports is available on Anterix's financial statements page.

The most recent filing was a Form 8-K/A submitted on April 21, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:ATEX) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners